[ASND] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
12-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -28.24%
YoY- -384.77%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 1,022 746 535 2,757 1,436 2,225 2,507 -45.05%
PBT -134,442 -62,983 -138,982 -121,760 -95,038 -63,394 -80,400 40.92%
Tax -68 -191 -17 -19 -106 -77 -38 47.44%
NP -134,374 -62,792 -138,965 -121,741 -94,932 -63,317 -80,362 40.92%
Tax Rate - - - - - - - -
Total Cost 135,396 63,538 139,500 124,498 96,368 65,542 82,869 38.76%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -13,148.14 -8,417.16 -25,974.77 -4,415.71 -6,610.86 -2,845.71 -3,205.50 156.45%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -2.50 -1.17 -2.60 -2.31 -1.97 -1.32 -1.68 30.37%
EPS Diluted -2.50 -1.17 -2.58 -2.31 -1.97 -1.32 -1.67 30.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.